CONTENTS:
- E-cigarette research needs to adopt open science practices to improve quality [Editorial]. Munafo M.R., West R., p. 3-4.
- Open science and pre-registration of studies and analysis plans. West R., p. 5.
- Are animal models of addiction useful? [Addiction opinion and debate]. Field M., Kersbergen I., p. 6-12.
- Lasting translation: how to improve animal models for addiction treatment. Muller C.P., p. 13-14.
- An imperfect model is still useful. Perry C.J., Lawrence A.J., p. 14-16.
- The relevance of animal models of addiction. Deroche-Gamonet V., p. 16-17.
- Response to commentaries. Field M., Kersbergen I., p. 17-18.
- A systematic review of research on adolescent solitary alcohol and marijuana use in the United States. Mason W.A., Stevens A.L., Fleming C.B., p. 19-31.
- Commentary on Mason et al. (2020): Choosing to consume alone and an increased risk of harm might have a common cause. Callinan S., MacLean S., p. 32-33.
- Impact of specialist and primary care stop smoking support on socio-economic inequalities in cessation in the United Kingdom: a systematic review and national equity initial review completed 22 January 2019; final version accepted 19 July 2019 analysis. Smith C.E., Hill S.E., Amos A., p. 34-46.
- Commentary on Smith et al. (2020): Equity positive impact of English Stop Smoking Services underlines need for comprehensive approach to public health interventions. Kock L., Brown J., p. 47-48.
- Impact of the introduction and withdrawal of financial incentives on the delivery of alcohol screening and brief advice in English primary health care: an interrupted time-series analysis. O'Donnell A., Angus C., Hanratty B., Hamilton F.L., Petersen I., Kaner E., p. 49-60.
- Does child maltreatment predict alcohol use disorders in young adulthood? A cohort study of linked notifications and survey data. Kisely S., Mills R., Strathearn L., Najman J.M., p. 61-68.
- Evaluation of adding the community reinforcement approach to motivational enhancement therapy for adults aged 60 years and older with DSM-5 alcohol use disorder: a randomized controlled trial. Andersen K., Behrendt S., Bilberg R., Bogenschutz M.P., Braun B., Buehringer G., et al., p. 69-81.
- Initiating buprenorphine treatment for opioid use disorder during short-term in-patient 'detoxification': a randomized clinical trial. Stein M., Herman D., Conti M., Anderson B., Bailey G., p. 82-94.
- Commentary on Stein et al. (2020): Whither detoxification in the face of the opioid epidemic? Nunes E.V., Shulman M., p. 95-96.
- Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada. Pilarinos A., Barker B., Nosova E., Milloy M.J., Hayashi K., Wood E., et al., p. 97-106.
- Commentary on Pilarinos et al. (2020): Scientific realism and the study of coerced substance use treatment. Urbanoski K.A., p. 107-108.
- Spatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring. Gonzalez-Marino I., Baz-Lomba J.A., Alygizakis N.A., Andres-Costa M.J., Bade R., Barron L.P., et al., p. 109-120.
- Identification and characterization of latent classes based on drug use among men who have sex with men at risk of sexually transmitted infections in Amsterdam, the Netherlands. Achterbergh R.C.A., de Vries H.J.C., Boyd A., Davidovich U., Druckler S., Hoornenborg E., et al., p. 121-133.
- Impact of early nausea on varenicline adherence and smoking cessation. Peng A.R., Swardfager W., Benowitz N.L., Ahluwalia J.S., Lerman C., Nollen N.L., et al., p. 134-144.
- The changing patterns and correlates of population-level polysubstance use in Australian youth: a multi-group latent class analysis of nationally representative samples spanning 12 years. Chan G., Connor J., Hall W., Leung J., p. 145-155.
- Commentary on Chan et al. (2020): Solving the puzzle of why substance use is declining among young people requires a multi-substance perspective. Ball J., p. 156-157.
- Therapist and computer-based brief interventions for drug use within a randomized controlled trial: effects on parallel trajectories of alcohol use, cannabis use and anxiety symptoms. Drislane L.E., Waller R., Martz M.E., Bonar E.E., Walton M.A., Chermack S.T., et al., p. 158-169.
- Association between snus use over time and smoking cessation in Norwegian smokers. Lund I., Christiansen S.G., p. 170-174.
- Psychostimulant use disorder and the heart. Duflou J., p. 175-183.
- The theory of Rational Addiction. Rogeberg O., p. 184-187.
- Medical marijuana laws, substance use treatment admissions and the ecological fallacy. Caputi T.L., p. 188-189.
- Medical marijuna laws: Response to Caputi. Meinhofer A., p. 189-190.
- Clinical applications of buprenorphine depot injection for opioid use disorder. Allikmets S., Vink J.P., p. 190.